Ayala Pharmaceuticals, Inc.
ADXS
Revenue
9.00k
▲5.00k▲125.00%
3 Months ChangeAssets
16.58M
▲9.60M▲137.49%
3 Months ChangeLiabilities
2.30M
▲397.00k▲20.83%
3 Months ChangeFree Cash Flow
-11.92M
▲1.91M▲13.82%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-04-03
Form 8-K
ID: 0000929638-24-001326
2024-03-29
Form 8-K
ID: 0000929638-24-001313
2024-03-05
Form 8-K
ID: 0000929638-24-000901
2024-02-23
Form 8-K
ID: 0000929638-24-000753
2024-02-09
Form 8-K
ID: 0000929638-24-000501
2024-02-06
Form 8-K
ID: 0001493152-24-005035
2023-11-20
Form 10-Q
ID: 0001493152-23-041998
2023-10-20
Form 8-K
ID: 0001493152-23-037852
2023-09-21
Form 8-K
ID: 0001493152-23-033336
2023-08-10
Form 10-Q
ID: 0001493152-23-027531